Guigue Nicolas, Lardeux Samuel, Alanio Alexandre, Hamane Samia, Tabouret Marc, Bretagne Stéphane
Laboratoire de Parasitologie-Mycologie, Groupe hospitalier Lariboisière-Saint Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Bio-Rad Laboratories, Steenvoorde, France.
PLoS One. 2015 Apr 10;10(4):e0124044. doi: 10.1371/journal.pone.0124044. eCollection 2015.
The Platelia Aspergillus Ag assay (Bio-Rad) is designed for detecting Aspergillus galactomannan (GM) and is widely used for diagnosing invasive aspergillosis but is hampered by variable occurrences of unreproducible positive results. Frequency and origin of these unreproducible results have not been formally studied.
Different technicians simultaneously performed four tests on 550 consecutive sera from adult patients (Test#1-Test#2 for extraction#1 and Test#3-Test#4 for extraction#2). The samples were classified as confirmed negative [all tests with GM optical density index (GM-ODI) <0.5], confirmed positive (all tests with GM-ODI ≥0.5), extraction unreproducible positive (Test#1 and Test#2 ODIs ≥0.5, and Test#3 and Test#4 GM-ODIs <0.5, or conversely), and ELISA unreproducible positive (only one test with GM-ODI ≥0.5). The samples with positive and negative GM-ODIs within the assay coefficient of variation values were classified as non-conclusive. Four similar additional tests were performed after ≤72h storage at 4 °C and a new GM test after 8 months at -20 °C.
Five-hundred-twenty sera (94.5%) were confirmed negative, 15 (2.7%) confirmed positive, 4 (0.7%) extraction unreproducible positive, 6 (1.1%) ELISA unreproducible positive, and 5 (0.9%) non-conclusive. Upon retesting, the unreproducible positive results turned negative except for one which turned non-conclusive. The confirmed positive and non-conclusive had similar GM-ODIs (p>0.4) upon retesting after storage ≤72h at 4 °C (n = 20) or eight months at -20 °C (n = 17).
Operational unreproducible positives represent 33% of the GM-positive results and a second sample evaluation appears mandatory to avoid useless investigations or treatments. When operational artifacts are excluded, GM remains stable at standard storage conditions.
普立泰曲霉菌半乳甘露聚糖检测试剂盒(Bio-Rad公司)旨在检测曲霉菌半乳甘露聚糖(GM),广泛用于侵袭性曲霉病的诊断,但不可重复的阳性结果时有发生,这对其应用造成了阻碍。尚未对这些不可重复结果的发生频率和来源进行正式研究。
不同技术人员对550例成年患者的连续血清样本同时进行四项检测(提取1的检测#1 - 检测#2以及提取2的检测#3 - 检测#4)。样本分为确诊阴性(所有检测的GM光密度指数(GM-ODI)<0.5)、确诊阳性(所有检测的GM-ODI≥0.5)、提取不可重复阳性(检测#1和检测#2的ODI≥0.5,检测#3和检测#4的GM-ODI<0.5,或相反情况)以及ELISA不可重复阳性(仅一项检测的GM-ODI≥0.5)。GM-ODI在检测变异系数范围内呈阳性和阴性的样本归类为不确定。在4℃储存≤72小时后进行四项类似的额外检测,并在-20℃储存8个月后进行一次新的GM检测。
520份血清(94.5%)确诊为阴性,15份(2.7%)确诊为阳性,4份(0.7%)提取不可重复阳性,6份(1.1%)ELISA不可重复阳性,5份(0.9%)不确定。再次检测时,除一份变为不确定外,不可重复的阳性结果均变为阴性。在4℃储存≤72小时(n = 20)或-20℃储存8个月(n = 17)后再次检测时,确诊阳性和不确定样本的GM-ODI相似(p>0.4)。
操作上不可重复的阳性结果占GM阳性结果的33%,为避免不必要的检查或治疗,似乎必须对第二个样本进行评估。排除操作假象后,GM在标准储存条件下保持稳定。